U.S. Markets closed

MVC Capital invests $9.5M in Biogenic Reagents

MVC Capital announced that it will invest $9.5M in Biogenic Reagents, a producer of high-performance carbon products made from renewable resources. Under the terms of the transaction, MVC has committed to provide a $9.5M senior secured convertible note to Biogenic in order to construct additional reactor capacity at the company's production facility located in Marquette, Michigan. The note will mature in five years.